Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Opioid Use Disorder: Is Reduced Usage A Better Endpoint Than Abstinence?

Apr 24 2018

• By Derrick Gingery

Related Content

Gottlieb's Priority For Proposed Opioid Money Is Mail Facilities

Feb 22 2018

Senate Draft Bill On Opioids Tasks US FDA With Clarifying Its Regulation Of New Treatments

Apr 06 2018

Opioid Withdrawal Symptom Mitigation Data Can Support A Labeling Claim

Mar 29 2018

Kratom Advocates Urge Industry Compliance, FDA And DEA Compassion

Mar 08 2018

Opioid Treatments Could Get Survival Claim As US FDA Develops Protocol

Dec 02 2017

FDA Ends Regularly Scheduled Patient-Focused Drug Development Meetings

Sep 29 2017

Addiction Recovery Medications' 'Stigma' Needs To Be Eliminated, Gottlieb Says

Oct 26 2017

Opioid Packaging: Is Non-Inferiority Enough For A New Claim?

Dec 12 2017

Opioid Spotlight: Trump Announces Plans For More Spending As Congress Introduces Two Dozen Bills

Mar 20 2018

Related Companies

US WorldMeds, LLC

Additional Topics

United States Drug Approval Standards Research & Development FDA Regulation Neurology BioPharmaceutical

More from Approval Standards

More from Pathways & Standards

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window